FDA Objects To Amarin Trade Complaint Against Omega-3 Ingredients

FDA Chief Counsel Rebecca Wood says Amarin's request for an ITC investigation necessarily turns on questions of drug and supplements policy, where it is the expert and authorized agency. If successful, Amarin's move could encourage others to similarly seek alternative forums for action.

FDASignBldg21Entrance_1200x675

FDA's chief counsel says Amarin Corp. PLC's request for the International Trade Commission to effectively shut down a large piece of the US omega-3 dietary supplement market is interfering with the agency's authority to regulate the industry.

Amarin filed a complaint with the FTC Aug. 30 asking it to investigate importation and sale of synthetically produced omega-3...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet